Then, a cell chemotaxis assay was performed, and the results showed that siRNA-mediated reduction in NPM1 significantly decreased CXCL12-induced number of chemotactic HCC cells (Figure 2a). The gene discussed is NPM1; the disease is hepatocellular carcinoma.